Cancer Pharma Industry

Cancer is one of the most daunting health challenges and a leading cause of death in every corner of the world. The global market for hematologic drugs is predicted to grow twice as fast as that of other pharmaceuticals over the next five years. Top companies include Janssen biotech, Novartis, Celgene, Johnson & Johnson and Amgen. The Pharma industry embraces hematology in producing various biological drugs and generic drugs with increasing investments, healthcare expenditures and growth in cancer pharmaceutical companies. The NCI states that the medical costs of cancer care are $125 billion with the rise of 39 percent to $173 billion by the upcoming year. The most common moto of the cancer industry is that it employs too many people and produces too much income to allow for a cure to be found.

  • Track 1-1 Cancer Pharmaceutical Companies
  • Track 2-2 Biological Drugs
  • Track 3-3 Generic Drugs

Related Conference of Hematology